Lotus Health Group Company carries a market capitalization of 20.69B, placing it among publicly traded companies globally. Its enterprise value stands at 8.87B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 20.69B |
| Enterprise Value | 8.87B |
Lotus Health Group Company currently has 1.79B shares outstanding.
| Shares Outstanding | 1.79B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Lotus Health Group Company trades at a trailing price-to-earnings ratio of 37.76. The price-to-sales ratio is 3.26, and the price-to-book ratio stands at 12.75.
| PE Ratio | 37.76 |
| PS Ratio | 3.26 |
| PB Ratio | 12.75 |
| P/TBV Ratio | 6.54 |
| P/FCF Ratio | 36.55 |
| P/OCF Ratio | N/A |
On an enterprise value basis, Lotus Health Group Company trades at an EV/EBITDA multiple of 21.24 and an EV/FCF ratio of 29.51. The EV/Sales ratio of 2.91 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.24 provides insight into valuation relative to core operating earnings.
| EV / Sales | 2.91 |
| EV / EBITDA | 21.24 |
| EV / EBIT | 21.24 |
| EV / FCF | 29.51 |
Lotus Health Group Company maintains a current ratio of 1.75, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 32.38, indicating elevated leverage, while an interest coverage ratio of 10.31 demonstrates strong ability to service its debt obligations.
| Current Ratio | 1.75 |
| Quick Ratio | 1.19 |
| Debt / Equity | 32.38 |
| Debt / EBITDA | 1.27 |
| Interest Coverage | 10.31 |
Lotus Health Group Company posts a return on equity of 40.65 and a return on invested capital of 14.48.
| Return on Equity (ROE) | 40.65 |
| Return on Assets (ROA) | 8.67 |
| Return on Invested Capital (ROIC) | 14.48 |
| Return on Capital Employed (ROCE) | 30.92 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 15.63 |
Over the trailing twelve months, Lotus Health Group Company has paid 103.84M in income taxes, reflecting an effective tax rate of 28.53.
| Income Tax | 103.84M |
| Effective Tax Rate | 28.53 |
Lotus Health Group Company's stock has gained approximately 93.62416% over the past 52 weeks. The 50-day moving average sits at 11.59, while the 200-day moving average is 7.54.
| Beta (5Y) | N/A |
| 52-Week Price Change | 93.62416% |
| 50-Day Moving Average | 11.59 |
| 200-Day Moving Average | 7.54 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Lotus Health Group Company generated 3.05B in revenue and converted that into 263.09M in net income, yielding earnings per share of 0.16. EBITDA reached 417.75M, while operating income came in at 417.75M.
| Revenue | 3.05B |
| Gross Profit | 841.54M |
| Operating Income | 417.75M |
| Pretax Income | 363.97M |
| Net Income | 263.09M |
| EBITDA | 417.75M |
| EBIT | 417.75M |
| Earnings Per Share (EPS) | 0.16 |
Lotus Health Group Company holds 1.42B in cash and equivalents against 529.95M in total debt, resulting in a net debt position of -916.53M. Total book value stands at 779.08M, with working capital of 900.94M providing operational flexibility.
| Cash & Cash Equivalents | 1.42B |
| Total Debt | 529.95M |
| Net Debt | -916.53M |
| Equity (Book Value) | 779.08M |
| Book Value Per Share | 0.47 |
| Working Capital | 900.94M |
After subtracting -271.78M in capital expenditures, free cash flow totaled -271.78M - equivalent to -0.16 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -271.78M |
| Free Cash Flow | -271.78M |
| FCF Per Share | -0.16 |
Lotus Health Group Company operates with a gross margin of 27.63, reflecting its pricing power and cost economics. The operating margin of 13.72 and net profit margin of 8.64 provide insight into operational efficiency.
| Gross Margin | 27.63 |
| Operating Margin | 13.72 |
| Pretax Margin | 11.95 |
| Profit Margin | 8.64 |
| EBITDA Margin | 13.72 |
The company's payout ratio of 13.95 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.02 |
| Dividend Yield | N/A |
| Payout Ratio | 13.95 |
| Shareholder Yield | 0.26 |
| FCF Yield | 2.74 |
Lotus Health Group Company's most recent stock split took place on January 21, 2020 with a 1000:1299 split ratio.
| Last Split Date | 1/21/2020 |
| Split Ratio | 1000:1299 |
Lotus Health Group Company posts an Altman Z-Score of 5.35, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.35 |